Novartis, a Switzerland-based pharmaceutical company, will use its expertise in breast cancer therapies alongside IBM Watson Health’s cognitive computing capabilities. The two companies will develop a cognitive solution that uses real-world data and analytics to provide physicians with insight into optimal breast cancer treatment combinations for individual patients.
“As the industry shifts toward value-based care, it’s critical for clinicians to understand the real-world outcomes of therapeutics on subsets of their patients, and our goal ultimately is to put those insights into oncologists’ hands,” said Anil Jain, MD, chief medical informatics officer at IBM Watson Health.
More articles on health IT:
Mount Sinai launches for-profit genomics company
4 questions with Henry Ford Health System CIO Mary Alice Annecharico
Cerner names new leadership for Middle East region
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
